製品名:6-Hydroxy-N,2-dimethylbenzofuran-3-carboxamide

IUPAC Name:6-hydroxy-N,2-dimethyl-1-benzofuran-3-carboxamide

CAS番号:638217-08-0
分子式:C11H11NO3
純度:97%
カタログ番号:CM160779
分子量:205.21

包装単位 有効在庫 価格(USD) 数量
CM160779-1g in stock ǺȤȋ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:638217-08-0
分子式:C11H11NO3
融点:-
SMILESコード:CNC(=O)C1=C(C)OC2=C1C=CC(O)=C2
密度:
カタログ番号:CM160779
分子量:205.21
沸点:259.1°C at 760 mmHg
MDL番号:MFCD09836137
保管方法:Store at 2-8°C.

Category Infos

Benzofurans
Benzofuran is an aromatic heterocyclic organic compound with the chemical formula C8H6O. It is a colorless oily liquid at room temperature with an aromatic odor. Benzofuran can be volatilized with water vapor and can be decomposed by potassium permanganate and other oxidants. It is an intermediate for the preparation of amiodarone and indene resin. Benzofuran derivatives are important pharmaceutical intermediates.
Benzofuran | C8H6O | CID 9223 -Chemenu
Benzofuran | C8H6O | CID 9223 |Where to Buy Benzofurans
Benzofuran is the heterocyclic compound consisting of fused benzene and furan rings. This colourless liquid is a component of coal tar.Benzofuran is extracted from coal tar. It is also obtained by dehydrogenation of 2-ethylphenol.

Column Infos

Fruquintinib
November 08, 2023, FDA has approved FRUZAQLA(fruquintinib), an oral targeted therapy for adults with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy.
FRUZAQLA is the first and only selective inhibitor of all three VEGF receptor kinases approved in the U.S. for previously treated mCRC regardless of biomarker status.

Related Products